Literature DB >> 769953

Phase I study of corynebacterium parvum in patients with solid tumors.

P R Band, C Jao-King, R C Urtasun, M Haraphongse.   

Abstract

Nineteen patients with various solid tumors were treated with Corynebacterium parvum for 10 consecutive days at doses ranging from 0.5 to 6 mg/m2. Major toxic effects included rigors and cyanosis, hypertension, headache, nausea, and vomiting. Toxicity was maximal during the first 3 days of treatment and decreased or even disappeared when, on subsequent days, increasing doses of the vaccine were given. Objective tumor regressions were observed in four patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 769953

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


  3 in total

1.  Personal experience with Corynebacterium parvum in human cancers.

Authors:  L Israël; R Edelstein
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

Review 2.  Cancer immunotherapy.

Authors:  S P Richman; J U Gutterman; E M Hersh
Journal:  Can Med Assoc J       Date:  1979-02-03       Impact factor: 8.262

3.  A preliminary study of intravenous methanol extraction residue of BCG in treatment of advanced cancer.

Authors:  E Robinson; A Bartal; J Honigman; Y Cohen
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.